Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism

Metabolism: Clinical and Experimental

Volumn 45, Issue 1, 1996, Pages 24-27

  Castelo Branco, Camil ^a,b   Martínez De Osaba, María J ^a   Martínez, Sergio ^a   Fortuny, Albert ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HORMONE RESPONSE; HUMAN; HYPERANDROGENISM; HYPOPHYSIS ADRENAL SYSTEM; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 13344270407     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90195-X     Document Type: Article

References (24)

1. Jeffcoate W: The treatment of women with hirsutism. Clin Endocrinol (oxf) 39:143-150, 1993
2. Rittmaster RS: Use of gonadotropin-releasing hormone agonists in the treatment of hyperandrogenism. Clin Obstet Gynecol 36:679-689, 1993
3. Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447, 1961
4. Schally AV, Redding TW, Coramu-Schally AM: Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH. Prostate 4:545-552, 1983
5. Castelo-Branco C, Martinez de Osaba MJ, Vanrell JA, et al: Effects of oophorectomy and hormone replacement therapy on pituitary-gonadal function. Maturitas 17:101-111, 1993
6. Cusan L, Dupont A, Gómez JL, et al: Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial. Fertil Steril 61:281-287, 1994
7. Cusan L, Dupont A, Bélanger A, et al: Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol 23:462-469, 1990
8. Falsetti L, Dordoni D, Gastaldi C, et al: A new association of ethinylestradiol and cyproterone acetate in the therapy of polycystic ovary syndrome. Acta Eur Fertil 17:19-25, 1986
9. Tremblay RR: Treatment of hirsutism with spironolactone. J Clin Endocrinol Metab 15:363-371, 1986
10. Falsetti L, Pasinetti E: Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism. Fertil Steril 61:817-822, 1994
11. Balasch J, Gómez F, Casamitjana R, et al: Pituitary-ovarian suppression by the standard and half-doses of D-trp-6-luteinizing hormone-releasing hormone depot. Hum Reprod 7:1230-1234, 1992
12. Falsetti L, Pasinetti E, Chioda C, et al: Treatment of moderate and severe hirsutism with a gonadotrophin-releasing hormone agonist. Hum Reprod 7:894, 1992
13. Hsueh AJW, Erickson GF: Extrapituitary action of gonadotropin-releasing hormone: Direct inhibition of ovarian steroidogenesis. Science 204:854-855, 1979
14. Pellicer A, Miro F: Steroidogenesis in vitro of human granulosa cells pretreated in vitro with gonadotropin-releasing hormone analogs. Fertil Steril 54:590-596, 1990
15. Loumaye E, Coen G, Pampfer S, et al: Use of gonadotropin-releasing hormone agonist during ovarian stimulation leads to significant concentration of peptide in follicular fluids. Fertil Steril 52:256-263, 1989
16. Richardson GS: Hormonal physiology of the ovary adrenal cortex, in Gold JJ, Josimovitch JB (eds): Gynecologic Endocrinology. New York, NY, Plenum, 1987, p 65
17. Aakvaag A: Pathways in the biosynthesis of androstenedione in the human ovary in vitro. Acta Endocrinol (Copenh) 60:517-526, 1969
18. Dennefors BL, Janson P, Knutson F, et al: Steroid production and responsiveness to gonadotrophin in isolated stromal tissue of human menopausal ovaries. Am J Obstet Gynecol 136:997-1002, 1980
19. Florensa E, Sommerville IF, Harrison RF, et al: Plasma 20α-dihydroprogesterone, progesterone, and 17-hydroxyprogester one: Daily and four-hourly variations during the menstrual cycle. J Steroid Biochem 7:769-777, 1976
20. Holmdahl TH, Johansson EDB: Peripheral plasma levels of 17a-hydroxyprogesterone, progesterone and oestradiol during normal menstrual cycle in women. Acta Endocrinol (Copenh) 71:743-754, 1972
21. 1-dehydrogenase and aromatase in immature rat ovary. J Steroid Biochem 14:1369-1377, 1981
22. 17-20-lyase activities. Endocrinology 111:1201-1208, 1982
23. Ehrmann DA, Rosenfield RL, Barnes RB, et al: Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162, 1992
24. Carmina E, Janni A, Lobo R: Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism. J Clin Endocrinol Metab 78:126-130, 1994